Obituary of Frances Oldham Kelsey, 1914-2015

ISSN 2516-5852 (Online)

To read or download this Journal in a magazine format on ISSUU, please click here

AIMS Journal, 2019, Vol 31, No 3

By Marein Schmitthenner, doula and AIMS volunteer

Frances Oldham Kelsey was a Canadian-American pharmacologist and physician. As a reviewer for the U.S. Food and Drug Administration (FDA), she saved thousands of babies from thalidomide by refusing to authorise the drug for the U.S. market due to safety concerns. Her stance led to much tougher drug testing and new laws regulating pharmaceuticals.

Frances Oldham was born on Vancouver Island in British Columbia on 24 July 1914, the daughter of Frank and Katherine Stuart Oldham. She had an unusual career for a woman at the time – she earned a master’s degree in science in 1935 and a PhD in pharmacology in 1938. By 1942, she was studying possible cures for malaria at the University of Chicago. This led her to become increasingly interested in drugs that pass from mother to fetus through the placenta.

She got married in 1943 and she and her husband had two daughters. She continued her studies and received a medical degree from the University of Chicago in 1950.

After working as an editorial associate for the American Medical Association Journal, teaching pharmacology and practicing general medicine, in 1960 she accepted a job with the FDA, evaluating applications for licenses to market new drugs.

The pharmaceutical company Merrell’s application to licence thalidomide, a sedative that had been developed in Europe and was widely sold there since 1957, was one of the first cases Frances dealt with in her new job. Although the company claimed the drug was safely giving people deep, natural sleep and doctors had already been prescribing it to pregnant women in other parts of the world to suppress nausea, Frances found the safety evidence to be insufficient. She withheld approval and asked for more data on toxicity from controlled studies. A battle lasting months with Merrell ensued, during which time Frances was called ‘stubborn’ and ‘unreasonable’, but, luckily for thousands of American babies, she did not give in. About a year later, reports started to flood in from Europe and Africa about horrendous side effects and babies born with terrible malformations of their limbs. Merrell withdrew its application and the drug never made it onto the American market.

Dr. Kelsey’s strength of character and courage are all the more amazing considering the laws on the safety of pharmaceuticals were not rigorously enforced at the time. She could have done what everyone else at the FDA was doing, with approval often being routine, but Dr. Kelsey was a very intelligent woman and not easily fooled. She acted according to strict scientific and ethical principles and according to her own strong morals, and she was not afraid to speak up for what she believed in.

The Kennedy administration used the Thalidomide tragedy to pass stronger drug regulations, and the 1962 law required tighter proof of safety and effectiveness of new drugs, disclosure of side effects and the swift removal of unsafe drugs from the market.

Dr. Kelsey moved on to head up the Division of Scientific Investigations of the FDA, which ensured the scientific integrity of the data on which the agency’s decisions on drugs were based.

Her contributions have been widely recognized through Presidential and other awards. In 2000, she was inducted into the National Women’s Hall of Fame.

Francis Oldham Kelsey died on 7 August 2015 in her daughter’s home in London, Ontario, Canada.

The AIMS Journal spearheads discussions about change and development in the maternity services..

AIMS Journal articles on the website go back to 1960, offering an important historical record of maternity issues over the past 60 years. Please check the date of the article because the situation that it discusses may have changed since it was published. We are also very aware that the language used in many articles may not be the language that AIMS would use today.

To contact the editors, please email:

We make the AIMS Journal freely available so that as many people as possible can benefit from the articles. If you found this article interesting please consider supporting us by becoming an AIMS member or making a donation. We are a small charity that accepts no commercial sponsorship, in order to preserve our reputation for providing impartial, evidence-based information. You can make donations at Peoples Fundraising. To become an AIMS member or join our mailing list see Join AIMS

AIMS supports all maternity service users to navigate the system as it exists, and campaigns for a system which truly meets the needs of all.

Latest Content


« »

Report of Parliamentary Debate on B…

AIMS Journal, 2024, Vol 36, No 1 By Elle Gundry The first parliamentary debate on birth trauma took place in the House of Commons on Thursday 19th October 2023. [1] Thank…

Read more

Doulas supporting clients to make a…

AIMS Journal, 2024, Vol 36, No 1 By Anne Glover I work with women from all walks of life, but one thing that is important to them all, is having a positive and satisfying…

Read more

My Complaint

AIMS Journal, 2024, Vol 36, No 1 Editor’s note: In this quite shocking account of disrespect and neglect, Grace describes the arrival of her first baby. With Grace’s perm…

Read more


« »

MaMA conference - 26/ 27 April 2024

MaMa Conference is the largest & longest running annual midwifery & maternity conference in the UK. Over the past 12 amazing years we have created an original and unique…

Read more

AIMS Workshop: The Foundation Stone…

Join us for an interactive online AIMS workshop: " The Foundation Stones for Supporting the Physiological Process in Pregnancy and Birth ". In this workshop discussion we…

Read more

Annual Birth Trauma Summit

Read more

Latest Campaigns

« »

What are the priorities for midwife…

AIMS is proud to be supporting the RCM's Research Prioritisation project as a Project Partner and with one of our volunteers on the Steering Group…

Read more

Parliamentary Inquiry into Birth Tr…

Introduction to AIMS and why AIMS is making a submission Since 1960, AIMS has been the leading advocate for improvements in UK maternity care. We have national and intern…

Read more

BICS Conference poster: AIMS Campai…

AIMS Campaigns Team volunteers are presenting a poster about our campaign for Physiology-Informed Maternity Services at the 2023 conference of the British Intrapartum Car…

Read more